Ann: Change of Director's Interest Notice - Van Der Made, page-131

First 131 Last

Share
Profile

Follow
DingoBorat

2,837 Posts.

1314

30/06/21

21:23

Post #: 54190064
Share

Originally posted by Fact Finder ↑

We have had a small drop in the price of BRN’s share price which might continue today or not.

The same sort of drop occurred last year at the end of the financial year and some have reported that knowing this was likely to occur have taken the opportunity to sell and buy back even more BRN shares.

Some have not sold any BRN shares and continue to hold as they have for some years for great returns.

Some have come on here as first time ever posters to say they have been so concerned by the share price movement they have sold out and encouraged others to do the same.

So I ask myself what if anything should I be concerned about which this small drop in the share price the same as last year will be likely to cause:

1. One thing it will cause is some holders to question their judgment and decide to sell in something close to fear. This will make me sad for them but it does not actually affect Brainchip.

2. Institutions that have been accumulating will continue to accumulate picking up cheaply the shares of those at 1. above.

3. The short interests will be less worried and more comfortable with their short positions.

4. Trolls will try to eke out credibility from the fact that the share price has gone down.

5. TSMC will continue to manufacture the AKD1000 oblivious to all of the above.

6. Renesas will continue to work on implementing the AKIDA IP oblivious to all of the above.

7. Ford will continue to test AKD1000 under its EAP contract oblivious to all of the above.

8. Valeo will continue to test and implement AKIDA technology under its EAP contract oblivious to all of the above.

9. Vorago will continue with its EAP NASA funded program to harden AKD1000 oblivious to all of the above.

10. NASA will continue with its work under the EAP contract to explore the ways to implement AKIDA technology oblivious to all of the above.

11. NaNose will continue its strategic partnership with Brainchip oblivious to all of the above.

12. Biotome will continue its partnership with Brainchip oblivious to all of the above.

13. Magic-Eye will continue its partnership with Brainchip oblivious to all of the above.

14. Ten plus EAP customers under NDA’s will continue to do their testing oblivious to all of the above.

15. DELL Technologies will continue to explore the extent of AKIDA technologies scalability.

16. Brainchip will continue to advertise for and recruit engineers and scientists to meet customer demands.

17. Brainchip’s existing engineering teams and scientists will keep working on AKD500,1500 & 2000 and the cortical column oblivious to the above.

18. The sales and marketing team will continue to advance Brainchip in the market place oblivious to all of the above.

On reflection nothing has actually happened of any consequence whatsoever. Might well, not have even bothered with this post when you consider that nothing has actually happened.

My opinion only DYOR
FF

AKIDA Ballista

Expand

Very good, well reasoned and set out post FactFinder.
You know, I try to avoid giving you light bulbs, because I figure, you have enough already
But that post scored another one..

Has probably been mentioned already, but those locking away BRN shares in their Super fund, using the 20% rule which some have.
Should check their percentages again, as they can now add more.
If they haven't already done so.

Not financial advice.

BRN Price at posting: 49.0¢ Sentiment: Buy Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint